FOLFOX + targeted therapy vs FOLFOX
Tumour response · people with metastatic CRC
FOLFOX + targeted therapy probably leads to higher overall tumour response compared with FOLFOX (moderate certainty).
1 finding from 1 review
- Second‐line systemic therapy for metastatic colorectal cancer 2017 · Cochrane Headline outcomes onlyRR 2.64 [1.71, 4.06]1 study · 578 participantsModerate